SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-021733
Filing Date
2017-04-05
Accepted
2017-04-05 17:18:25
Documents
7
Period of Report
2017-04-03
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-10836_18k.htm 8-K 49908
2 EX-10.1 a17-10836_1ex10d1.htm EX-10.1 748657
3 EX-10.2 a17-10836_1ex10d2.htm EX-10.2 260513
4 EX-99.1 a17-10836_1ex99d1.htm EX-99.1 18329
5 GRAPHIC g108361ki19i001.jpg GRAPHIC 2503
6 GRAPHIC g108361ki19i002.jpg GRAPHIC 4468
7 GRAPHIC g108361mmi001.jpg GRAPHIC 2503
  Complete submission text file 0001104659-17-021733.txt   1092201
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10865 | Film No.: 17743503
SIC: 2834 Pharmaceutical Preparations